Logo image of MAXN

MAXEON SOLAR TECHNOLOGIE (MAXN) Stock Fundamental Analysis

NASDAQ:MAXN - Nasdaq - SGXZ57724486 - Common Stock - Currency: USD

3.58  +0.05 (+1.42%)

Fundamental Rating

1

MAXN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. MAXN may be in some trouble as it scores bad on both profitability and health. MAXN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MAXN had negative earnings in the past year.
In the past year MAXN has reported a negative cash flow from operations.
In the past 5 years MAXN always reported negative net income.
MAXN had negative operating cash flow in 4 of the past 5 years.
MAXN Yearly Net Income VS EBIT VS OCF VS FCFMAXN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

MAXN has a worse Return On Assets (-151.06%) than 97.27% of its industry peers.
Industry RankSector Rank
ROA -151.06%
ROE N/A
ROIC N/A
ROA(3y)-70.69%
ROA(5y)-50.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAXN Yearly ROA, ROE, ROICMAXN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MAXN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MAXN Yearly Profit, Operating, Gross MarginsMAXN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

More info and screens

0

2. Health

2.1 Basic Checks

MAXN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MAXN has more shares outstanding
Compared to 5 years ago, MAXN has less shares outstanding
MAXN has a worse debt/assets ratio than last year.
MAXN Yearly Shares OutstandingMAXN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MAXN Yearly Total Debt VS Total AssetsMAXN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MAXN has an Altman-Z score of -7.62. This is a bad value and indicates that MAXN is not financially healthy and even has some risk of bankruptcy.
MAXN has a worse Altman-Z score (-7.62) than 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.62
ROIC/WACCN/A
WACC5.9%
MAXN Yearly LT Debt VS Equity VS FCFMAXN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 0.78 indicates that MAXN may have some problems paying its short term obligations.
With a Current ratio value of 0.78, MAXN is not doing good in the industry: 94.55% of the companies in the same industry are doing better.
A Quick Ratio of 0.67 indicates that MAXN may have some problems paying its short term obligations.
MAXN has a Quick ratio of 0.67. This is amonst the worse of the industry: MAXN underperforms 93.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.67
MAXN Yearly Current Assets VS Current LiabilitesMAXN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 84.01% over the past year.
Looking at the last year, MAXN shows a very negative growth in Revenue. The Revenue has decreased by -54.68% in the last year.
Measured over the past years, MAXN shows a very negative growth in Revenue. The Revenue has been decreasing by -15.74% on average per year.
EPS 1Y (TTM)84.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.85%
Revenue 1Y (TTM)-54.68%
Revenue growth 3Y-13.38%
Revenue growth 5Y-15.74%
Sales Q2Q%-73.96%

3.2 Future

Based on estimates for the next years, MAXN will show a very strong growth in Earnings Per Share. The EPS will grow by 41.42% on average per year.
MAXN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 38.94% yearly.
EPS Next Y99.98%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year54.92%
Revenue Next 2Y38.94%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MAXN Yearly Revenue VS EstimatesMAXN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MAXN Yearly EPS VS EstimatesMAXN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAXN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MAXN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAXN Price Earnings VS Forward Price EarningsMAXN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MAXN Per share dataMAXN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100

4.3 Compensation for Growth

MAXN's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MAXN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAXEON SOLAR TECHNOLOGIE

NASDAQ:MAXN (7/21/2025, 9:30:00 AM)

3.58

+0.05 (+1.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)N/A N/A
Inst Owners3.35%
Inst Owner Change0%
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap60.50M
Analysts43.33
Price Target2.14 (-40.22%)
Short Float %12.84%
Short Ratio4.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.1%
Min EPS beat(2)82.1%
Max EPS beat(2)84.1%
EPS beat(4)2
Avg EPS beat(4)24.23%
Min EPS beat(4)-57.06%
Max EPS beat(4)84.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-47.76%
Min Revenue beat(2)-79.98%
Max Revenue beat(2)-15.54%
Revenue beat(4)1
Avg Revenue beat(4)-24.68%
Min Revenue beat(4)-79.98%
Max Revenue beat(4)2.03%
Revenue beat(8)1
Avg Revenue beat(8)-14.81%
Revenue beat(12)4
Avg Revenue beat(12)-9.38%
Revenue beat(16)5
Avg Revenue beat(16)-7.75%
PT rev (1m)-82.5%
PT rev (3m)-96.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)15.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-141.63
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-19.05
FCFYN/A
OCF(TTM)-15.98
OCFYN/A
SpS41.22
BVpS-17.4
TBVpS-17.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -151.06%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-70.69%
ROA(5y)-50.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 120.93%
Cap/Sales 7.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.67
Altman-Z -7.62
F-Score2
WACC5.9%
ROIC/WACCN/A
Cap/Depr(3y)118.42%
Cap/Depr(5y)155.85%
Cap/Sales(3y)7.42%
Cap/Sales(5y)9.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.85%
EPS Next Y99.98%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-54.68%
Revenue growth 3Y-13.38%
Revenue growth 5Y-15.74%
Sales Q2Q%-73.96%
Revenue Next Year54.92%
Revenue Next 2Y38.94%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-392.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year94.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.3%
OCF growth 3YN/A
OCF growth 5YN/A